$AIZ

Assurant, Inc. Stock 12‑Month Price Target Cut to $326.67, Implies 22% Upside

Analysts lowered Assurant's 12-month price target from $330 to $326.67, with a range of $300 to $355. This implies 22% upside from the Oct. 2 close. The consensus rating remains 'Buy' among 10 analysts.

Original reporting
Published Oct 5, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Assurant, Inc. Stock 12‑Month Price Target Cut to $326.67, Implies 22% Upside — source image
Decision brief

The 30-second read

$AIZBearishMed
01

Why it matters

The modest target reduction may trigger short‑term selling pressure, though the new target still indicates upside from current levels, creating a mixed signal for traders.

02

Market read

Analyst price‑target adjustments are a common catalyst; this change is modest but may influence short‑term trading decisions on AIZ.

03

What to watch

Potential upcoming earnings or regulatory developments could further influence the stock beyond the analyst target change.

Relevance 5/10Novelty 5/10Timing: today

Background

Assurant is a U.S. insurer providing specialty and standard property‑casualty products. Analyst price‑target updates are routine but can affect short‑term price action.

Company-level read

Ticker impact

$AIZBearishMedium confidence
Context

Analysts cut Assurant's average price target to $326.67, down from $330, implying about 22% upside from the Oct. 2 close.

Expected impact

likely modest downside as the market prices in the lower target

Evidence & confidence

A price‑target cut usually leads to short‑term selling pressure, even though the new target still suggests upside from current levels.

Market effects

Minimal; the change reflects analyst view on Assurant's insurance underwriting rather than a sector‑wide shift.

Limited to U.S. insurance stocks, with no broader market effect.

Low; the news is company‑specific and does not affect global markets.

Counterpoint

Some traders may view the cut as an opportunity to buy, given the still‑high upside implied by the new target.

Key entities

  • Assurant, Inc.

    U.S. insurance provider whose price target was cut.

Related articles

$AIZMedAI 8/10

Do Wall Street Analysts Like Assurant Stock?

Assurant (AIZ) stock has risen 34.7% over the past year, outperforming the S&P 500. Q2 2026 revenue was $3.5B, up 6.9% YoY, with adjusted EPS of $6.41. Analysts expect 11.5% EPS growth for the year. Nine analysts rate it 'Strong Buy,' with a mean price target of $321.43, implying 11.4% upside.

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.